News | April 20, 2026
Lupin subsidiary settles US antitrust case with Humana for $30 Million
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
Allergan also presented new insights on the growing population of patients on GLP-1 agonists for weight loss who are seeking aesthetic treatments
The company’s ACC lineup underscores a growing body of evidence backing the drug’s performance beyond controlled trials
Nearly 12 million people are estimated to be living with glaucoma, making the country one of the worst affected globally
Motorica India conducted a specialised masterclass led by Shumaev, centred on real-life rehabilitation scenarios and personalised therapy programs before and after prosthetic fitting
Subscribe To Our Newsletter & Stay Updated
